These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 39218361)
1. The potential of exosomes as a new therapeutic strategy for glioblastoma. Cunha Silva L; Branco F; Cunha J; Vitorino C; Gomes C; Carrascal MA; Falcão A; Miguel Neves B; Teresa Cruz M Eur J Pharm Biopharm; 2024 Oct; 203():114460. PubMed ID: 39218361 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Wang D; Wang C; Wang L; Chen Y Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona. Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569 [TBL] [Abstract][Full Text] [Related]
4. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
5. Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines. Shan T; Wang W; Fan M; Bi J; He T; Sun Y; Zheng M; Yan D J Control Release; 2024 Jun; 370():866-878. PubMed ID: 38685386 [TBL] [Abstract][Full Text] [Related]
6. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy. Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K Int J Pharm; 2024 Jul; 660():124262. PubMed ID: 38815637 [TBL] [Abstract][Full Text] [Related]
7. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment. Ganipineni LP; Danhier F; Préat V J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958 [TBL] [Abstract][Full Text] [Related]
8. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598 [TBL] [Abstract][Full Text] [Related]
9. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Fang X; Gong R; Yang D; Li C; Zhang Y; Wang Y; Nie G; Li M; Peng X; Zhang B J Am Chem Soc; 2024 Jun; 146(22):15251-15263. PubMed ID: 38780071 [TBL] [Abstract][Full Text] [Related]
10. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
11. Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy. Tran K; Brice R; Yao L Neurochem Int; 2021 Jul; 147():105049. PubMed ID: 33945833 [TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature. Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514 [TBL] [Abstract][Full Text] [Related]
13. Drug delivery approaches for the treatment of glioblastoma multiforme. Fakhoury M Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399 [TBL] [Abstract][Full Text] [Related]
14. Current Challenges and Opportunities in Treating Glioblastoma. Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750 [TBL] [Abstract][Full Text] [Related]
15. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804 [TBL] [Abstract][Full Text] [Related]
16. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma. Li M; Zhang X; Zhou Y; Chu Y; Shen J; Cai Y; Sun X Int J Nanomedicine; 2024; 19():6999-7014. PubMed ID: 39011386 [TBL] [Abstract][Full Text] [Related]
17. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine. Martins C; Sarmento B Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374 [TBL] [Abstract][Full Text] [Related]
18. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010 [TBL] [Abstract][Full Text] [Related]
19. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma. Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167 [TBL] [Abstract][Full Text] [Related]
20. Harnessing nanomedicine for therapeutic intervention in glioblastoma. Gutkin A; Cohen ZR; Peer D Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]